These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37112719)

  • 1. Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on "Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India.
    Royal A; John D; Bharti O; Tanwar R; Bhagat DK; Padmawati RS; Chaudhary V; Umapathi R; Bhadola P; Utarini A
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India.
    Kapur V
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India.
    Royal A; John D; Bharti O; Tanwar R; Bhagat DK; Padmawati RS; Chaudhary V; Umapathi R; Bhadola P; Utarini A
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines.
    Quiambao B; Varghese L; Demarteau N; Sengson RF; Javier J; Mukherjee P; Manio LC; Preiss S
    Int J Infect Dis; 2020 Aug; 97():38-46. PubMed ID: 32450291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure rabies prophylaxis: a systematic review.
    Kessels JA; Recuenco S; Navarro-Vela AM; Deray R; Vigilato M; Ertl H; Durrheim D; Rees H; Nel LH; Abela-Ridder B; Briggs D
    Bull World Health Organ; 2017 Mar; 95(3):210-219C. PubMed ID: 28250534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study.
    WHO Rabies Modelling Consortium
    Lancet Infect Dis; 2019 Jan; 19(1):102-111. PubMed ID: 30472178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting children from rabies with education and pre-exposure prophylaxis: A school-based campaign in El Nido, Palawan, Philippines.
    Deray R; Rivera C; Gripon S; Ulanday C; Roces MC; Amparo AC; Attlan M; Demont C; Kieffer A; Miranda ME
    PLoS One; 2018; 13(1):e0189596. PubMed ID: 29293571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of rabies post exposure prophylaxis in Iran.
    Hatam N; Esmaelzade F; Mirahmadizadeh A; Keshavarz K; Rajabi A; Afsar Kazerooni P; Ataollahi M
    J Res Health Sci; 2014; 14(2):122-7. PubMed ID: 24728746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
    Wang C; Dulal P; Zhou X; Xiang Z; Goharriz H; Banyard A; Green N; Brunner L; Ventura R; Collin N; Draper SJ; Hill AVS; Ashfield R; Fooks AR; Ertl HC; Douglas AD
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006870. PubMed ID: 30372438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review.
    Anothaisintawee T; Julienne Genuino A; Thavorncharoensap M; Youngkong S; Rattanavipapong W; Meeyai A; Chaikledkaew U
    Vaccine; 2019 Oct; 37 Suppl 1():A146-A153. PubMed ID: 30554795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?
    Bernard KW; Fishbein DB
    Vaccine; 1991 Nov; 9(11):833-6. PubMed ID: 1759505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route.
    Denis M; Knezevic I; Wilde H; Hemachudha T; Briggs D; Knopf L
    Vaccine; 2019 Oct; 37 Suppl 1():A99-A106. PubMed ID: 30551985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
    Malerczyk C; Vakil HB; Bender W
    Hum Vaccin Immunother; 2013 Jul; 9(7):1454-9. PubMed ID: 23571224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route.
    Ravish HS; Srikanth J; Ashwath Narayana DH; Annadani R; Vijayashankar V; Undi M
    Hum Vaccin Immunother; 2013 Sep; 9(9):1910-3. PubMed ID: 23787889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation.
    Suijkerbuijk AW; Mangen MJ; Haverkate MR; Luppino FS; Bantjes SE; Visser LG; Swaan CM; Ruijs WL; Over EA
    Euro Surveill; 2020 Sep; 25(38):. PubMed ID: 32975187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expert consensus on pre-exposure rabies prophylaxis].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(39):3103-3111. PubMed ID: 37840181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
    Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C
    Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of sustainable provision of intradermal post exposure prophylaxis against rabies at primary care level--evidence from rural Haryana.
    Salve H; Kumar S; Sa R; Rai SK; Kant S; Pandav CS
    BMC Health Serv Res; 2014 Jun; 14():278. PubMed ID: 24965875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania.
    Shim E; Hampson K; Cleaveland S; Galvani AP
    Vaccine; 2009 Nov; 27(51):7167-72. PubMed ID: 19925948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the intra-cluster correlation coefficient for evaluating an educational intervention program to improve rabies awareness and dog bite prevention among children in Sikkim, India: A pilot study.
    Auplish A; Clarke AS; Van Zanten T; Abel K; Tham C; Bhutia TN; Wilks CR; Stevenson MA; Firestone SM
    Acta Trop; 2017 May; 169():62-68. PubMed ID: 28040481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.